BRISTOL-MYERS SQUIBB COMPANY Payments for (Proceeds from) Other Investing Activities
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Payments for (Proceeds from) Other Investing Activities of $37.00 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-10-24.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromOtherInvestingActivities · last filed 2014-10-24
- BRISTOL-MYERS SQUIBB COMPANY payments for (proceeds from) other investing activities for the quarter ending 2014-09-30 was -$123.00M.
- BRISTOL-MYERS SQUIBB COMPANY payments for (proceeds from) other investing activities for the quarter ending 2014-06-30 was $139.00M.
- BRISTOL-MYERS SQUIBB COMPANY payments for (proceeds from) other investing activities for the quarter ending 2014-03-31 was $21.00M.
- BRISTOL-MYERS SQUIBB COMPANY payments for (proceeds from) other investing activities for the quarter ending 2013-12-31 was -$1.00M.
- BRISTOL-MYERS SQUIBB COMPANY payments for (proceeds from) other investing activities for fiscal 2013 was -$9.00M.
- BRISTOL-MYERS SQUIBB COMPANY payments for (proceeds from) other investing activities for fiscal 2012 was -$68.00M.
- BRISTOL-MYERS SQUIBB COMPANY payments for (proceeds from) other investing activities for fiscal 2011 was -$149.00M.
- BRISTOL-MYERS SQUIBB COMPANY payments for (proceeds from) other investing activities for fiscal 2010 was -$67.00M.
| Period end | Payments for (Proceeds from) Other Investing Activities 3 month | Payments for (Proceeds from) Other Investing Activities 6 month | Payments for (Proceeds from) Other Investing Activities 9 month | Payments for (Proceeds from) Other Investing Activities 12 month |
|---|---|---|---|---|
| 2014-09-30 | -$123.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $16.00M derived: sum of 2 quarters · filed 2014-10-24 | $37.00M 10-Q · filed 2014-10-24 | $36.00M derived: sum of 4 quarters · filed 2014-10-24 |
| 2014-06-30 | $139.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $160.00M 10-Q · filed 2014-07-24 | $159.00M derived: sum of 3 quarters · filed 2014-07-24 | $154.00M derived: sum of 4 quarters · filed 2014-07-24 |
| 2014-03-31 | $21.00M 10-Q · filed 2014-04-29 | $20.00M derived: sum of 2 quarters · filed 2014-04-29 | $15.00M derived: sum of 3 quarters · filed 2014-04-29 | $15.00M derived: sum of 4 quarters · filed 2014-07-24 |
| 2013-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | -$6.00M derived: sum of 2 quarters · filed 2014-02-14 | -$6.00M derived: sum of 3 quarters · filed 2014-07-24 | -$9.00M 10-K · filed 2014-02-14 |
| 2013-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | -$5.00M derived: sum of 2 quarters · filed 2014-07-24 | -$8.00M 10-Q · filed 2013-10-23 | -$60.00M derived: sum of 4 quarters · filed 2014-07-24 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | -$3.00M 10-Q · filed 2014-07-24 | -$55.00M derived: sum of 3 quarters · filed 2014-07-24 | -$56.00M derived: sum of 4 quarters · filed 2014-07-24 |
| 2013-03-31 | -$3.00M 10-Q · filed 2014-04-29 | -$55.00M derived: sum of 2 quarters · filed 2014-04-29 | -$56.00M derived: sum of 3 quarters · filed 2014-04-29 | -$59.00M derived: sum of 4 quarters · filed 2014-04-29 |
| 2012-12-31 | -$52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | -$53.00M derived: sum of 2 quarters · filed 2014-02-14 | -$56.00M derived: sum of 3 quarters · filed 2014-02-14 | -$68.00M 10-K · filed 2014-02-14 |
| 2012-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-23 | -$4.00M derived: sum of 2 quarters · filed 2013-10-23 | -$16.00M 10-Q · filed 2013-10-23 | -$18.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | -$15.00M 10-Q · filed 2013-07-25 | -$17.00M derived: sum of 3 quarters · filed 2014-02-14 | -$42.00M derived: sum of 4 quarters · filed 2014-02-14 |
| 2012-03-31 | -$12.00M 10-Q · filed 2013-04-25 | -$14.00M derived: sum of 2 quarters · filed 2014-02-14 | -$39.00M derived: sum of 3 quarters · filed 2014-02-14 | |
| 2011-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | -$27.00M derived: sum of 2 quarters · filed 2014-02-14 | -$149.00M 10-K · filed 2014-02-14 | |
| 2011-09-30 | -$25.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | -$147.00M 10-Q · filed 2012-10-24 | ||
| 2011-06-30 | -$122.00M 10-Q · filed 2012-07-25 | |||
| 2010-12-31 | -$67.00M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |